Morgan Stanley Call 130 6MK 16.01.../ DE000MB9KN59 /
21/06/2024 20:08:30 | Var.0.00 | Denaro22:00:34 | Lettera22:00:34 | Sottostante | Prezzo di esercizio | Expiration date | Tipo di opzione |
---|---|---|---|---|---|---|---|
1.68EUR | 0.00% | - Quantità in denaro: - |
- Quantità in lettera: - |
MERCK CO. D... | 130.00 - | 16/01/2026 | Call |
GlobeNewswire
03:00
Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Dir...
GlobeNewswire
02:45
Novotech Liver Cancer Research Landscape Report Finds 1,700 Trials Initiated Globally
GlobeNewswire
01:44
ROSEN, LEADING INVESTOR COUNSEL, Encourages UiPath, Inc. Investors to Secure Counsel Before Importan...
GlobeNewswire
01:35
ROSEN, LEADING INVESTOR COUNSEL, Encourages NIKE, Inc. Investors to Secure Counsel Before Important ...
GlobeNewswire
22/06
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of MacroGenics, In...
GlobeNewswire
22/06
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Masimo Corporati...
GlobeNewswire
22/06
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of FutureFuel Corp....
GlobeNewswire
22/06
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Bolt Biotherapeu...
GlobeNewswire
22/06
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Regeneron Pharma...